South Korean Orthopedic Biomaterials Market, 2020-2026: Trends & Developments, Procedure Numbers, Product Assessment, Competitive Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Biomaterials Market Report Suite | South Korea | 2020-2026 | Medsuite” report has been added to ResearchAndMarkets.com’s offering.

This report includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. The report also includes hyaluronic acid (HA) viscosupplementation.

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee.

In 2019, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth across all segments of the orthopedic biomaterials market.

Key Topics Covered

1. EXECUTIVE SUMMARY

• South Korean Orthopedic Biomaterials Market Overview
• Competitive Analysis
• Market Trends
• Market Developments
• Procedure Numbers
• Markets Included
• Research Methodology
  

2. PRODUCT ASSESSMENT

2.1 INTRODUCTION

2.2 PRODUCT PORTFOLIOS

• Bone Graft Substitutes
• Growth Factors
• Other Products
• Hyaluronic Acid Viscosupplementation (HAV)

2.3 REGULATORY ISSUES AND RECALLS

• Bone Graft Substitutes
• Allografts
• MTF
• DBM
• AlloSource
• SeaSpine
• RTI Surgical
• Synthetics
• Abyrx
• Zimmer Biomet
• Growth Factors
• Medtronic
• Hyaluronic Acid Viscosupplementation
• Three-injection
• Ferring Pharmaceuticals

2.4 CLINICAL TRIALS

• Bone Graft Substitutes
• Allografts
• Providence Medical Technology
• The University of Texas Health Science
• University of Winchester
• BDM
• K2M
• Zimmer Biomet
• Synthetics
• Baxter
• Bonesupport
• DePuy Synthes
• NuVasive
• RTI surgical
• Sunstar GUIDOR
• Other materials and comparison
• Seoul National University Hospital.
• Sewon Cellontech
• SurgaColl Technologies Limited
• University of Colorado
• University of Padova
• Growth Factors
• Bioventus
• Cerapedics
• CGBio
• Isto
• Medtronic
• NuVasive
• Wright
• Others
• Hyaluronic Acid Viscosupplementation
• Anika Therapeutics
• Bioventus
• Cairo University
• Ferring Pharmaceuticals
• Federal University of Minas Gerais
• Fidia Pharma USA Inc.
• Istituto Ortopedico Rizzoli
• University Hospital
• Universidade Nova de Lisboa

3. SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

3.1 INTRODUCTION

• Bone Graft Substitutes
• Growth Factors
• Hyaluronic Acid (HA) Viscosupplementation

3.2 CURRENCY EXCHANGE RATE

3.3 MARKET OVERVIEW AND TREND ANALYSIS

3.4 DRIVERS AND LIMITERS

• Market Drivers
• Market Limiters

3.5 COMPETITIVE MARKET SHARE ANALYSIS

3.6 MERGERS AND ACQUISITIONS

3.7 COMPANY PROFILES

• Anika Therapeutics
• Bioventus
• DePuy Synthes
• Ferring Pharmaceuticals
• Fidia Pharmaceuticals
• Genzyme (Sanofi Group)
• Harvest Technologies (Terumo BCT)
• Integra LifeSciences
• Medtronic
• Musculoskeletal Transplant Foundation (MTF)
• NuVasive
• Orthofix
• RTI Surgical
• Stryker
• Vericel Corporation (formerly Aastrom Bioscience)
• Zimmer Biomet

3.8 SWOT ANALYSIS

• Anika Therapeutics
• Bioventus
• DePuy Synthes
• Ferring Pharmaceuticals
• Fidia Pharmaceuticals
• Harvest Technologies (Terumo BCT)
• Integra LifeSciences
• Medtronic
• Musculoskeletal Transplant Foundation (MTF)
• NuVasive
• Orthofix
• Stryker
• Vericel Corporation (formerly Aastrom Bioscience)
• Zimmer Biomet

4. PROCEDURE NUMBERS

4.1 INTRODUCTION

4.2 PROCEDURES

• Orthopedic Biomaterial Procedures by Segment
• Orthopedic Bone Grafting Procedures
• Units per Procedure by Indication
• Orthopedic Bone Grafting Procedures by Material
• Autograft Procedures by Indication
• Allograft Procedures by Indication
• DBM Procedures by Indication
• Synthetic Procedures by Indication
• Orthopedic Bone Grafting Procedures by Indication
• Hyaluronic Acid Viscosupplementation Procedures
• Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle

5. ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION

5.2 MARKET OVERVIEW

• Orthopedic Bone Graft Substitute Market by Material
• Orthopedic Bone Graft Substitute Market by Indication

5.3 MARKET ANALYSIS AND FORECAST

• Total Orthopedic Bone Graft Substitute Market
• Orthopedic Bone Graft Substitute Market by Material
• Allograft Bone Graft Substitute Market
• Allograft Bone Graft Substitute Market by Indication
• Demineralized Bone Matrix Allograft Bone Graft Substitute Market
• Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication
• Synthetic Bone Graft Substitute Market
• Synthetic Bone Graft Substitute Market by Indication
• Orthopedic Bone Graft Substitute Market by Indication
• Spine Bone Graft Substitute Market
• Cervical Spine Bone Graft Substitute Market
• Thoracolumbar Spine Bone Graft Substitute Market
• Trauma Bone Graft Substitute Market
• Non-Union Trauma Bone Graft Substitute Market
• Fresh Fracture Trauma Bone Graft Substitute Market
• Large Joint Reconstruction Bone Graft Substitute Market
• Hip Reconstruction Bone Graft Substitute Market
• Knee Reconstruction Bone Graft Substitute Market
• Foot Reconstruction Bone Graft Substitute Market
• Craniomaxillofacial Bone Graft Substitute Market
• Oncology Bone Graft Substitute Market

5.4 DRIVERS AND LIMITERS

• Market Drivers
• Market Limiters

5.5 COMPETITIVE MARKET SHARE ANALYSIS

6. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

6.1 INTRODUCTION

• Benefits of Viscosupplementation
• Synovial Fluid

6.2 MARKET OVERVIEW

6.3 MARKET ANALYSIS AND FORECAST

• Total Hyaluronic Acid Viscosupplementation Market
• Single-Injection Hyaluronic Acid Viscosupplementation Market
• Three-Injection Hyaluronic Acid Viscosupplementation Market
• Five-Injection Hyaluronic Acid Viscosupplementation Market

6.4 DRIVERS AND LIMITERS

• Market Drivers
• Market Limiters

6.5 COMPETITIVE MARKET SHARE ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/r/8do8pc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900